You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 5, May 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Increased Phospholipid Breakdown in Schizophrenia

Evidence for the Involvement of a Calcium-Independent Phospholipase A2

Brian M. Ross, PhD; Craig Hudson, MD; Jeffrey Erlieft; Jerry J. Warsh, MD, PhD; Stephen J. Kish, PhD

Arch Gen Psychiatry. 1997;54(5):487-494.


Abstract

Background
Magnetic resonance spectroscopy studies have suggested above-normal turnover of membrane phospholipids in brains of patients with schizophrenia. One possible explanation for these findings is increased activity of the phospholipid-catabolizing enzyme phospholipase A2 (PLA2). However, attempts to demonstrate higher PLA2 activity in the serum of subjects with schizophrenia have led to conflicting results. We hypothesized that this was due to serum PLA2 activity consisting of a family of different enzymes, with each group of investigators measuring activity of different PLA2 forms.

Design
Activity of PLA2 in serum samples obtained from 24 individuals with schizophrenia was compared with serum obtained from 33 age- and sex-matched control subjects, using both fluorometric and radiometrie assays with different substrates. Each method had previously yielded conflicting results concerning the status of the enzyme in schizophrenia.

Results
With the fluorometric assay, serum PLA2 activity in individuals with schizophrenia was markedly increased by 49% compared with control subjects (P<.001 ). In contrast, radiometrie assay of the same serum samples resulted in PLA2 activity not significantly different between patients and control subjects. Further investigations demonstrated that, whereas the radiometrie assay measured activity of a calcium-dependent enzyme, the fluorometric assay detected a calcium-insensitive enzyme possessing an acid-neutral pH optimum.

Conclusions
Increased calcium-independent PLA2 activity was seen in the serum of patients with schizophrenia. This change, if present also in the brain, may well explain the increased levels of phosphodiesters observed using magnetic resonance spectroscopy and therefore may contribute to the pathophysiological features of the disorder.



Author Affiliations

From the Clarke Institute of Psychiatry (Drs Ross, Hudson, Warsh, and Kish and Mr Erlich), the Departments of Psychiatry (Drs Ross, Warsh, and Kish) and Pharmacology (Drs Warsh and Kish), and the Institute of Medical Science (Drs Hudson, Warsh, and Kish), University of Toronto, Toronto, Ontario.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders
Farooqui et al.
Pharmacol. Rev. 2006;58:591-620.
ABSTRACT | FULL TEXT  

Aberrant Tyrosine Transport Across the Cell Membrane in Patients With Schizophrenia
Flyckt et al.
Arch Gen Psychiatry 2001;58:953-958.
ABSTRACT | FULL TEXT  

Activation of Neutrophil Calcium-Dependent and -Independent Phospholipases A2 by Organochlorine Compounds
Tithof et al.
Toxicol Sci 2000;53:40-47.
ABSTRACT | FULL TEXT  

Differential determination of phospholipase A2 and PAF-acetylhydrolase in biological fluids using fluorescent substrates
Kitsiouli et al.
J. Lipid Res. 1999;40:2346-2356.
ABSTRACT | FULL TEXT  

Calcium-Independent Phospholipase A2 and Schizophrenia
Smalheiser et al.
Arch Gen Psychiatry 1998;55:752-753.
FULL TEXT  

Three independent lines of evidence suggest retinoids as causal to schizophrenia
Goodman
Proc. Natl. Acad. Sci. USA 1998;95:7240-7244.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.